Compare CTMX & BZH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CTMX | BZH |
|---|---|---|
| Founded | 2008 | 1985 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Homebuilding |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 596.2M | 672.0M |
| IPO Year | 2015 | 1994 |
| Metric | CTMX | BZH |
|---|---|---|
| Price | $5.97 | $25.05 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 7 | 3 |
| Target Price | $8.86 | ★ $32.00 |
| AVG Volume (30 Days) | ★ 3.7M | 625.0K |
| Earning Date | 03-05-2026 | 01-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 50.22 | N/A |
| EPS | 0.24 | ★ 0.33 |
| Revenue | $113,631,000.00 | ★ $2,266,093,000.00 |
| Revenue This Year | N/A | $8.45 |
| Revenue Next Year | N/A | $12.21 |
| P/E Ratio | ★ $23.67 | $75.15 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.40 | $17.37 |
| 52 Week High | $6.35 | $27.29 |
| Indicator | CTMX | BZH |
|---|---|---|
| Relative Strength Index (RSI) | 54.53 | 60.28 |
| Support Level | $5.17 | $20.31 |
| Resistance Level | $6.35 | $24.96 |
| Average True Range (ATR) | 0.50 | 1.07 |
| MACD | -0.05 | 0.06 |
| Stochastic Oscillator | 29.01 | 92.27 |
CytomX Therapeutics Inc a clinical-stage, oncology-focused biopharmaceutical company developing novel, masked, conditionally activated biologics designed to be localized to the tumor microenvironment. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.
Beazer Homes USA Inc is an construction company that focuses on residential construction. The company specializes in single-family housing and multi-unit building construction in states and metro markets. Beazer Homes builds homes and communities that target first-time, move-up, and luxury homebuyers with an average selling price of roughly $300,000. From a geographic perspective, home sales in the western and eastern United States have been the sources of revenue for the company. Its segments involve: West segment that includes Arizona, California, Nevada, and Texas; East segment that includes Delaware, Indiana, Maryland, Tennessee, and Virginia; and Southeast segment which includes Florida, Georgia, North Carolina, and South Carolina.